| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |